Cargando…

Mammalian Target of Rapamycin Inhibitors Induce Tumor Cell Apoptosis In Vivo Primarily by Inhibiting VEGF Expression and Angiogenesis

We found that rapalog mTOR inhibitors induce G1 arrest in the PTEN-null HS Sultan B-cell lymphoma line in vitro, but that administration of rapalogs in a HS Sultan xenograft model resulted in significant apoptosis, and that this correlated with induction of hypoxia and inhibition of neoangiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frost, Patrick, Berlanger, Eileen, Mysore, Veena, Hoang, Bao, Shi, YiJiang, Gera, Joseph, Lichtenstein, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603547/ https://www.ncbi.nlm.nih.gov/pubmed/23533410 http://dx.doi.org/10.1155/2013/897025

Ejemplares similares

MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses
por: Shi, Yijiang, et al.
Publicado: (2014)

DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells
por: Yang, Yonghui, et al.
Publicado: (2014)

Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma
por: Gasperini, Paola, et al.
Publicado: (2009)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation
por: Vega, Mario, et al.
Publicado: (2022)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo
por: Gastelum, Gilberto, et al.
Publicado: (2023)

Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo
por: Xie, Hua, et al.
Publicado: (2012)

Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
por: Gasperini, P, et al.
Publicado: (2009)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis
por: Rumney, Robin M. H., et al.
Publicado: (2019)

Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis
por: Li, Xiaowu, et al.
Publicado: (2019)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1)
por: Demirkan, Gokhan, et al.
Publicado: (2011)

Fetal endoderm primarily holds the temporal and positional information required for mammalian intestinal development
Publicado: (1994)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

VEGF tips its hand in angiogenesis
por: Short, Ben
Publicado: (2015)

Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
por: Cartland, Siân P., et al.
Publicado: (2016)

A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo
por: Zhang, Yuan, et al.
Publicado: (2017)

Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-Induced Apoptosis Involves Mammalian Target of Rapamycin/Fkbp12-Rapamycin–Associated Protein–Mediated P53 Phosphorylation
por: Castedo, Maria, et al.
Publicado: (2001)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

The cytotoxic T cell proteome and its shaping by mammalian Target of Rapamycin
por: Hukelmann, Jens L., et al.
Publicado: (2015)

The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
por: Yoon, Mee-Sup
Publicado: (2017)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

Deletion of ARGLU1 causes global defects in alternative splicing in vivo and mouse cortical malformations primarily via apoptosis
por: Yao, Fenyong, et al.
Publicado: (2023)

Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle
por: Rosner, Margit, et al.
Publicado: (2009)

Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin
por: Shi, Hongbo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ts8a5vduhcjb7vvog3v21nmiqn